Adeno-associated virus (AAV) vector-based gene therapy Market Report

China Adeno-associated virus (AAV) vector-based gene therapy Industry Market Research Report 2023-2029

  • POSTDATE：Sep 09, 2023
  • PAGES：183
  • REPORT CODE：GMM1785037
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Adeno-associated virus (AAV) vector-based gene therapy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Sarepta Therapeutics

    • Spark Therapeutics

    • Amicus Therapeutics

    • BioMarin Pharmaceutical

    • NightstaRx

    • Sangamo Therapeutics

    • Pfizer

    • uniQure

    • Regenxbio

    By Type:

    • Self-complementary AAV (scAAV)

    • Single-stranded AAV (ssAAV)

    By Application:

    • Nervous system disease

    • Lysosomal storage disease

    • Hemophilia

    • Other

    • Ophthalmology

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Adeno-associated virus (AAV) vector-based gene therapy Market Overview 2018-2029

    • 1.1 China Adeno-associated virus (AAV) vector-based gene therapy Industry Development Overview

    • 1.2 China Adeno-associated virus (AAV) vector-based gene therapy Industry Development History

    • 1.3 China Adeno-associated virus (AAV) vector-based gene therapy Industry Market Size (2018-2029)

    • 1.4 China Adeno-associated virus (AAV) vector-based gene therapy Market Analysis by Type from Production Side

      • 1.4.1 China Adeno-associated virus (AAV) vector-based gene therapy Production Volume, Production Value and Growth Rate of Self-complementary AAV (scAAV) (2018-2029)

      • 1.4.2 China Adeno-associated virus (AAV) vector-based gene therapy Production Volume, Production Value and Growth Rate of Single-stranded AAV (ssAAV) (2018-2029)

    • 1.5 China Adeno-associated virus (AAV) vector-based gene therapy Market Analysis by Application from Consumption End

      • 1.5.1 China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume, Sales Value and Growth Rate of Nervous system disease (2018-2029)

      • 1.5.2 China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume, Sales Value and Growth Rate of Lysosomal storage disease (2018-2029)

      • 1.5.3 China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume, Sales Value and Growth Rate of Hemophilia (2018-2029)

      • 1.5.4 China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.5 China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume, Sales Value and Growth Rate of Ophthalmology (2018-2029)

    • 1.6 China Adeno-associated virus (AAV) vector-based gene therapy Market Analysis by Region

      • 1.6.1 North China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate from 2018-2029

    Chapter 2 China Adeno-associated virus (AAV) vector-based gene therapy Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Adeno-associated virus (AAV) vector-based gene therapy Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Adeno-associated virus (AAV) vector-based gene therapy Market Status and Competition Analysis in 2023

      • 2.2.3 China Adeno-associated virus (AAV) vector-based gene therapy Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Adeno-associated virus (AAV) vector-based gene therapy Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Adeno-associated virus (AAV) vector-based gene therapy Industry Development

    Chapter 3 Adeno-associated virus (AAV) vector-based gene therapyIndustry Chain Analysis

    • 3.1 Adeno-associated virus (AAV) vector-based gene therapy Industry Chain

    • 3.2 Adeno-associated virus (AAV) vector-based gene therapy Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Adeno-associated virus (AAV) vector-based gene therapy Market

    • 3.3 Adeno-associated virus (AAV) vector-based gene therapy Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Adeno-associated virus (AAV) vector-based gene therapy Market

    Chapter 4 China Adeno-associated virus (AAV) vector-based gene therapy Market, by Type

    • 4.1 China Adeno-associated virus (AAV) vector-based gene therapy Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Adeno-associated virus (AAV) vector-based gene therapy Total Production Volume and Growth Rate from Production Side

    • 4.5 China Adeno-associated virus (AAV) vector-based gene therapy Production Volume and Growth Rate, by Type

      • 4.5.1 China Adeno-associated virus (AAV) vector-based gene therapy Production Volume and Growth Rate of Self-complementary AAV (scAAV)

      • 4.5.2 China Adeno-associated virus (AAV) vector-based gene therapy Production Volume and Growth Rate of Single-stranded AAV (ssAAV)

    Chapter 5 China Adeno-associated virus (AAV) vector-based gene therapy Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Adeno-associated virus (AAV) vector-based gene therapy Total Market Size and Growth Rate from Consumption End

    • 5.5 China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate, by Application

      • 5.5.1 China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate of Nervous system disease

      • 5.5.2 China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate of Lysosomal storage disease

      • 5.5.3 China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate of Hemophilia

      • 5.5.4 China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate of Other

      • 5.5.5 China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate of Ophthalmology

    Chapter 6 China Adeno-associated virus (AAV) vector-based gene therapy Market, by Region

    • 6.1 China Adeno-associated virus (AAV) vector-based gene therapy Production Volume and Production Value, by Region

    • 6.2 China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume and Sales Value, by Region

    Chapter 7 North China Adeno-associated virus (AAV) vector-based gene therapy Market Analysis

    • 7.1 North China Adeno-associated virus (AAV) vector-based gene therapy Market, by Type

    • 7.2 North China Adeno-associated virus (AAV) vector-based gene therapy Market, by Application

    Chapter 8 Central China Adeno-associated virus (AAV) vector-based gene therapy Market Analysis

    • 8.1 Central China Adeno-associated virus (AAV) vector-based gene therapy Market, by Type

    • 8.2 Central China Adeno-associated virus (AAV) vector-based gene therapy Market, by Application

    Chapter 9 South China Adeno-associated virus (AAV) vector-based gene therapy Market Analysis

    • 9.1 South China Adeno-associated virus (AAV) vector-based gene therapy Market, by Type

    • 9.2 South China Adeno-associated virus (AAV) vector-based gene therapy Market, by Application

    Chapter 10 East China Adeno-associated virus (AAV) vector-based gene therapy Market Analysis

    • 10.1 East China Adeno-associated virus (AAV) vector-based gene therapy Market, by Type

    • 10.2 East China Adeno-associated virus (AAV) vector-based gene therapy Market, by Application

    Chapter 11 Northeast China Adeno-associated virus (AAV) vector-based gene therapy Market Analysis

    • 11.1 Northeast China Adeno-associated virus (AAV) vector-based gene therapy Market, by Type

    • 11.2 Northeast China Adeno-associated virus (AAV) vector-based gene therapy Market, by Application

    Chapter 12 Southwest China Adeno-associated virus (AAV) vector-based gene therapy Market Analysis

    • 12.1 Southwest China Adeno-associated virus (AAV) vector-based gene therapy Market, by Type

    • 12.2 Southwest China Adeno-associated virus (AAV) vector-based gene therapy Market, by Application

    Chapter 13 Northwest China Adeno-associated virus (AAV) vector-based gene therapy Market Analysis

    • 13.1 Northwest China Adeno-associated virus (AAV) vector-based gene therapy Market, by Type

    • 13.2 Northwest China Adeno-associated virus (AAV) vector-based gene therapy Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Sarepta Therapeutics

        • 14.1.1 Sarepta Therapeutics Company Profile

        • 14.1.2 Sarepta Therapeutics Adeno-associated virus (AAV) vector-based gene therapy Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Spark Therapeutics

        • 14.2.1 Spark Therapeutics Company Profile

        • 14.2.2 Spark Therapeutics Adeno-associated virus (AAV) vector-based gene therapy Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Amicus Therapeutics

        • 14.3.1 Amicus Therapeutics Company Profile

        • 14.3.2 Amicus Therapeutics Adeno-associated virus (AAV) vector-based gene therapy Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 BioMarin Pharmaceutical

        • 14.4.1 BioMarin Pharmaceutical Company Profile

        • 14.4.2 BioMarin Pharmaceutical Adeno-associated virus (AAV) vector-based gene therapy Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 NightstaRx

        • 14.5.1 NightstaRx Company Profile

        • 14.5.2 NightstaRx Adeno-associated virus (AAV) vector-based gene therapy Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Sangamo Therapeutics

        • 14.6.1 Sangamo Therapeutics Company Profile

        • 14.6.2 Sangamo Therapeutics Adeno-associated virus (AAV) vector-based gene therapy Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Pfizer

        • 14.7.1 Pfizer Company Profile

        • 14.7.2 Pfizer Adeno-associated virus (AAV) vector-based gene therapy Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 uniQure

        • 14.8.1 uniQure Company Profile

        • 14.8.2 uniQure Adeno-associated virus (AAV) vector-based gene therapy Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Regenxbio

        • 14.9.1 Regenxbio Company Profile

        • 14.9.2 Regenxbio Adeno-associated virus (AAV) vector-based gene therapy Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Adeno-associated virus (AAV) vector-based gene therapy Industry Research Conclusions

    • 15.2 Adeno-associated virus (AAV) vector-based gene therapy Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Industry Market Size (2018-2029)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Production Volume, Production Value and Growth Rate of Self-complementary AAV (scAAV) (2018-2029)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Production Volume, Production Value and Growth Rate of Single-stranded AAV (ssAAV) (2018-2029)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume, Sales Value and Growth Rate of Nervous system disease (2018-2029)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume, Sales Value and Growth Rate of Lysosomal storage disease (2018-2029)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume, Sales Value and Growth Rate of Hemophilia (2018-2029)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume, Sales Value and Growth Rate of Ophthalmology (2018-2029)

    • Figure North China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate from 2018-2029

    • Figure Central China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate from 2018-2029

    • Figure South China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate from 2018-2029

    • Figure East China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate from 2018-2029

    • Figure Adeno-associated virus (AAV) vector-based gene therapy Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Market Share by Type in 2018

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Market Share by Type in 2023

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Production Volume and Growth Rate of Self-complementary AAV (scAAV) (2018-2023)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Production Volume and Growth Rate of Single-stranded AAV (ssAAV) (2018-2023)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Market Share by Application in 2018

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Market Share by Application in 2023

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Total Market Size and Growth Rate from Consumption End

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate of Nervous system disease (2018-2023)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate of Lysosomal storage disease (2018-2023)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate of Hemophilia (2018-2023)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate of Other (2018-2023)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Market Size and Growth Rate of Ophthalmology (2018-2023)

    • Table China Adeno-associated virus (AAV) vector-based gene therapy Production Volume by Region (2018-2023)

    • Table China Adeno-associated virus (AAV) vector-based gene therapy Production Volume Share by Region (2018-2023)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Production Volume Share by Region (2018-2023)

    • Table China Adeno-associated virus (AAV) vector-based gene therapy Production Value by Region (2018-2023)

    • Table China Adeno-associated virus (AAV) vector-based gene therapy Production Value Share by Region (2018-2023)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Production Value Share by Region (2018-2023)

    • Table China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume by Region (2018-2023)

    • Table China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume Share by Region (2018-2023)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume Share by Region (2018-2023)

    • Table China Adeno-associated virus (AAV) vector-based gene therapy Sales Value by Region (2018-2023)

    • Table China Adeno-associated virus (AAV) vector-based gene therapy Sales Value Share by Region (2018-2023)

    • Figure China Adeno-associated virus (AAV) vector-based gene therapy Sales Value Share by Region (2018-2023)

    • Table North China Adeno-associated virus (AAV) vector-based gene therapy Production Volume by Type (2018-2023)

    • Table North China Adeno-associated virus (AAV) vector-based gene therapy Production Volume Share by Type (2018-2023)

    • Figure North China Adeno-associated virus (AAV) vector-based gene therapy Production Volume Share by Type (2018-2023)

    • Table North China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume by Application (2018-2023)

    • Table North China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume Share by Application (2018-2023)

    • Figure North China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume Share by Application (2018-2023)

    • Table Central China Adeno-associated virus (AAV) vector-based gene therapy Production Volume by Type (2018-2023)

    • Table Central China Adeno-associated virus (AAV) vector-based gene therapy Production Volume Share by Type (2018-2023)

    • Figure Central China Adeno-associated virus (AAV) vector-based gene therapy Production Volume Share by Type (2018-2023)

    • Table Central China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume by Application (2018-2023)

    • Table Central China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume Share by Application (2018-2023)

    • Figure Central China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume Share by Application (2018-2023)

    • Table South China Adeno-associated virus (AAV) vector-based gene therapy Production Volume by Type (2018-2023)

    • Table South China Adeno-associated virus (AAV) vector-based gene therapy Production Volume Share by Type (2018-2023)

    • Figure South China Adeno-associated virus (AAV) vector-based gene therapy Production Volume Share by Type (2018-2023)

    • Table South China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume by Application (2018-2023)

    • Table South China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume Share by Application (2018-2023)

    • Figure South China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume Share by Application (2018-2023)

    • Table East China Adeno-associated virus (AAV) vector-based gene therapy Production Volume by Type (2018-2023)

    • Table East China Adeno-associated virus (AAV) vector-based gene therapy Production Volume Share by Type (2018-2023)

    • Figure East China Adeno-associated virus (AAV) vector-based gene therapy Production Volume Share by Type (2018-2023)

    • Table East China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume by Application (2018-2023)

    • Table East China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume Share by Application (2018-2023)

    • Figure East China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume Share by Application (2018-2023)

    • Table Northeast China Adeno-associated virus (AAV) vector-based gene therapy Production Volume by Type (2018-2023)

    • Table Northeast China Adeno-associated virus (AAV) vector-based gene therapy Production Volume Share by Type (2018-2023)

    • Figure Northeast China Adeno-associated virus (AAV) vector-based gene therapy Production Volume Share by Type (2018-2023)

    • Table Northeast China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume by Application (2018-2023)

    • Table Northeast China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume Share by Application (2018-2023)

    • Table Southwest China Adeno-associated virus (AAV) vector-based gene therapy Production Volume by Type (2018-2023)

    • Table Southwest China Adeno-associated virus (AAV) vector-based gene therapy Production Volume Share by Type (2018-2023)

    • Figure Southwest China Adeno-associated virus (AAV) vector-based gene therapy Production Volume Share by Type (2018-2023)

    • Table Southwest China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume by Application (2018-2023)

    • Table Southwest China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume Share by Application (2018-2023)

    • Table Northwest China Adeno-associated virus (AAV) vector-based gene therapy Production Volume by Type (2018-2023)

    • Table Northwest China Adeno-associated virus (AAV) vector-based gene therapy Production Volume Share by Type (2018-2023)

    • Figure Northwest China Adeno-associated virus (AAV) vector-based gene therapy Production Volume Share by Type (2018-2023)

    • Table Northwest China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume by Application (2018-2023)

    • Table Northwest China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Adeno-associated virus (AAV) vector-based gene therapy Sales Volume Share by Application (2018-2023)

    • Table Sarepta Therapeutics Company Profile

    • Table Sarepta Therapeutics Adeno-associated virus (AAV) vector-based gene therapy Revenue, Price and Gross (2018-2023)

    • Table Spark Therapeutics Company Profile

    • Table Spark Therapeutics Adeno-associated virus (AAV) vector-based gene therapy Revenue, Price and Gross (2018-2023)

    • Table Amicus Therapeutics Company Profile

    • Table Amicus Therapeutics Adeno-associated virus (AAV) vector-based gene therapy Revenue, Price and Gross (2018-2023)

    • Table BioMarin Pharmaceutical Company Profile

    • Table BioMarin Pharmaceutical Adeno-associated virus (AAV) vector-based gene therapy Revenue, Price and Gross (2018-2023)

    • Table NightstaRx Company Profile

    • Table NightstaRx Adeno-associated virus (AAV) vector-based gene therapy Revenue, Price and Gross (2018-2023)

    • Table Sangamo Therapeutics Company Profile

    • Table Sangamo Therapeutics Adeno-associated virus (AAV) vector-based gene therapy Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Adeno-associated virus (AAV) vector-based gene therapy Revenue, Price and Gross (2018-2023)

    • Table uniQure Company Profile

    • Table uniQure Adeno-associated virus (AAV) vector-based gene therapy Revenue, Price and Gross (2018-2023)

    • Table Regenxbio Company Profile

    • Table Regenxbio Adeno-associated virus (AAV) vector-based gene therapy Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US